{"id":"W2021553032","doi":"10.1016/j.jhep.2014.10.035","title":"Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection","year":2014,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital","funders":"Janssen Pharmaceuticals; British Microcirculation Society; Gilead Sciences; Novartis; Gilead UK and Ireland Corporate Contributions; Roche; Merck; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Tenofovir alafenamide; Medicine; Tenofovir; Pharmacokinetics; Virology; Chronic hepatitis; Hepatitis B; Human immunodeficiency virus (HIV); Pharmacology; Virus; Viral load; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003446764,0.0001754583,0.00103736,0.0002547918,0.00005662071,0.000003274046,0.00004940199,0.0001070249,0.00002360593],"category_scores_gemma":[0.0002147962,0.0001347981,0.0001989156,0.0001035012,0.0002224702,0.00009285584,0.0000384923,0.0000936893,0.000001191054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002141381,"about_ca_system_score_gemma":0.0001864957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001046297,"about_ca_topic_score_gemma":0.002103925,"domain_scores_codex":[0.9985973,0.0001797205,0.0006633685,0.0001429338,0.0001874658,0.0002292532],"domain_scores_gemma":[0.9983051,0.0004104273,0.0007458989,0.0001393065,0.0003198209,0.0000794093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005154099,0.0005531734,0.8763297,0.0002719194,0.0005017053,0.00002044823,0.0002080625,0.000007627084,0.0464453,0.0001143096,0.0003457703,0.07468664],"study_design_scores_gemma":[0.009031611,0.01673164,0.7242213,0.0002281672,0.00116546,0.0005958191,0.000004872484,0.003665118,0.2172429,0.000360929,0.02656977,0.000182409],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931179,0.001151882,0.003512228,0.001012201,0.0005002305,0.0003327346,0.00003219545,0.000006854171,0.0003337427],"genre_scores_gemma":[0.9852149,0.01354989,0.0008020303,0.00004714104,0.0002971968,0.000007422222,0.000004586169,0.0000204914,0.00005629277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1707976,"threshold_uncertainty_score":0.5496907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0174453499360699,"score_gpt":0.3072132648366535,"score_spread":0.2897679149005836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}